Memory Training for Breast Cancer Survivors
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Cogmed Working Memory Training Program for breast cancer survivors?
Research shows that memory training can improve memory performance in breast cancer survivors, with improvements seen at a 2-month follow-up. Additionally, cognitive-behavioral treatments have been found to help manage memory and attention issues in breast cancer survivors, suggesting that similar cognitive training programs may be beneficial.12345
Is memory training safe for breast cancer survivors?
Memory training programs, like the Cogmed Working Memory Training Program, have been studied in various settings and are generally considered safe for humans. Participants in studies often report high satisfaction and improvements in cognitive function, with no significant safety concerns noted.12467
How does the Cogmed Working Memory Training Program treatment differ from other treatments for memory issues in breast cancer survivors?
The Cogmed Working Memory Training Program is unique because it is a web-based cognitive training specifically designed to improve working memory, which is often affected in breast cancer survivors. Unlike other treatments, it focuses on enhancing cognitive functions through structured online exercises, and there is no standard treatment for these cognitive complaints in breast cancer survivors.16789
What is the purpose of this trial?
The purpose of this study is to test a memory training program for breast cancer survivors who have problems with memory after receiving chemotherapy. Since breast cancer survivors have been reported to have trouble with their memory, a program to help these problems is important. Studies have shown that a 5-week software training program improved memory in pediatric cancer survivors and other disorders like stroke, but it has not been tested for breast cancer survivors. This study will see if breast cancer survivors can improve their memory and attention problems by using either one of two software versions of the program. One version is called Cogmed Working Memory Training, and the other is a comparison version of the software that has the same exercises but is less difficult. People who decide to participate in the study will be randomly given one of the two versions.
Research Team
Elizabeth Ryan, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
This trial is for female breast cancer survivors aged 18-69 who've had chemotherapy 1-10 years ago and are currently disease-free. They must speak English, have basic computer skills, internet access, and show memory problems on specific tests. Excluded are those with significant past brain injury or cognitive issues from other conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 5-week memory training program using one of two software versions to improve memory and attention problems
Follow-up
Participants complete two follow-up neurocognitive assessments to test for maintenance of treatment effect
Treatment Details
Interventions
- Cogmed Working Memory Training Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
MARTELL FOUNDATION
Collaborator